STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence

STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence

STERIS plc (NYSE:STE) is one of the best medical technology stocks to invest in. On February 5, Citizens reiterated its Market Outperform rating on STERIS plc (NYSE:STE) and kept the $280 price target on the shares. The firm made this move in reaction to STERIS’s Q3 FY2026 financial results.

STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence
STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence

STERIS beat revenue expectations by about 1% and matched profit forecasts. Management said growth was strong, with revenue up 7.1% over the past year and margins holding at 44.5%. Tariffs are expected to cost $55 million in FY2026, but cost control helped offset impacts. Despite this, STERIS kept its free cash flow outlook at $850 million, which analysts see as a strong position in medical technology.

Independent of the analyst action, on February 4, STERIS released its Q3 2026 earnings in which it reported adjusted earnings per share of $2.53. This figure matched Wall Street expectations. Quarterly revenue came in at $1.50 billion, exceeding estimates of about $1.48 billion. The figure is also a 9% year over year increase, which management explained was driven by demand across multiple business lines.

The company posted about 8% organic revenue growth on a constant-currency basis. This indicates underlying demand expansion rather than currency-related gains, noted management. Given this growth, STERIS reaffirmed its full-year fiscal 2026 guidance.

STERIS plc (NYSE:STE) provides medical technology products and services focused on infection prevention and procedural support. Its offerings include sterilizers, surgical tables, automated endoscope reprocessors, and operating room integration systems.

While we acknowledge the potential of STE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Foreign Stocks to Buy Right Now and 11 Best AI Penny Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

Source link